Interne link ProQR Therapeutics Announces Transaction Completed for Théa to Acquire Sepofarsen and Ultevursen Ophthalmic Assets december 08, 2023 om 12:30 PM UTC
Interne link ProQR Announces Third Quarter 2023 Operating and Financial Results november 07, 2023 om 12:00 PM UTC
Interne link ProQR Strengthens Leading Intellectual Property Estate for ADAR-mediated RNA Editing november 06, 2023 om 12:00 PM UTC
Interne link ProQR Announces Participation in the Chardan 7th Annual Genetic Medicines Conference september 28, 2023 om 12:00 PM UTC
Interne link ProQR Therapeutics Provides Update on Ophthalmic Assets september 27, 2023 om 11:00 AM UTC
Interne link ProQR Announces Webcast of Presentation at the Upcoming HC Wainwright 25th Annual Global Investment Conference september 07, 2023 om 12:00 PM UTC
Interne link ProQR Announces Second Quarter 2023 Operating and Financial Results augustus 03, 2023 om 11:00 AM UTC
Interne link ProQR Therapeutics and Laboratoires Théa Announce Agreement for Théa to Acquire ProQR’s Sepofarsen and Ultevursen Ophthalmic Assets augustus 01, 2023 om 11:00 AM UTC
Interne link ProQR to Present Data on its Axiomer® RNA Editing Technology at RNA Editing Summit juli 06, 2023 om 11:00 AM UTC
Interne link ProQR Announces First Quarter 2023 Operating and Financial Results mei 16, 2023 om 11:00 AM UTC
Interne link ProQR to Present its Axiomer® RNA Editing Technology at TIDES USA 2023 mei 09, 2023 om 12:00 PM UTC
Interne link ProQR Announces Upcoming Investor Conferences in April and May april 20, 2023 om 12:00 PM UTC
Interne link ProQR Announces Annual Meeting of Shareholders to be Held May 17, 2023 april 18, 2023 om 12:00 PM UTC
Interne link ProQR Announces Initial Pipeline Targets and Highlights Axiomer® RNA Editing Platform Technology at R&D Event maart 29, 2023 om 12:00 PM UTC
Interne link ProQR Announces Successful Defense of a Key Axiomer® Patent Protecting ADAR-mediated RNA Editing maart 14, 2023 om 12:00 PM UTC
Interne link ProQR to Present at Upcoming Scientific and Industry Conferences maart 07, 2023 om 01:00 PM UTC
Interne link ProQR Therapeutics to Host Virtual R&D Event on March 29, 2023 februari 28, 2023 om 01:00 PM UTC
Interne link ProQR Therapeutics Added to NASDAQ Biotechnology Index december 24, 2018 om 12:00 PM UTC
Interne link ProQR annonce la publication dans Nature Medicine des données du QR-110 pour l’amaurose congénitale de Leber 10 december 18, 2018 om 03:27 PM UTC
Interne link ProQR Announces Publication in Nature Medicine of QR-110 Data for Leber’s Congenital Amaurosis 10 december 17, 2018 om 04:52 PM UTC
Interne link ProQR Announces Strategic Changes to the Management Team and Key New Hires december 13, 2018 om 12:00 PM UTC
Interne link ProQR Receives € 4.7 million in Innovation Credit from Dutch Government for QR-110 for LCA10 december 10, 2018 om 12:00 PM UTC
Interne link ProQR Announces Clearance of IND to Start Clinical Trial of QR-421a in Usher Syndrome Type 2 Patients december 04, 2018 om 12:00 PM UTC
Interne link ProQR to Present at the Evercore ISI HealthConX Conference november 20, 2018 om 12:00 PM UTC
Interne link ProQR Announces Financial Results for the Third Quarter of 2018 november 07, 2018 om 12:00 PM UTC